General anesthesia in cesarean delivery linked with increased risk of postpartum depression

General anesthesia in cesarean delivery linked with increased risk of postpartum depression

A new study shows that having general anesthesia in a cesarean delivery is linked with significantly increased odds of severe postpartum depression requiring hospitalization, thoughts of suicide or self-inflicted injury. The findings from research conducted at Columbia University Mailman School of Public Health and Columbia University Irving Medical Center are published online in Anesthesia and Analgesia , the journal of the International Anesthesia Research Society. The study is the first to examine the effect of the mode of anesthesia for cesarean delivery on the risk of postpartum depression (PPD) and the possible protective effect of having regional anesthesia for cesarean delivery on maternal mental health compared with general anesthesia. Postpartum depression in the U.S. has increased seven-fold in the past 15 years, and it now affects up to 1 in 7 women, yielding about 550,000 annual new cases. General anesthesia for cesarean delivery may increase the risk of postpartum depression because it delays the initiation of mother to infant skin-to-skin interaction and breastfeeding, and often results in more acute and persistent postpartum pain. These situations are often coupled with a new mother's dissatisfaction with anesthesia in general, and can lead to negative mental health outcomes." Jean Guglielminotti, MD, PhD, in the Department of Anesthesiology and the Department of Epidemiology at Columbia Mailman School, and first author Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More